Status:
UNKNOWN
Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University
Lead Sponsor:
Ain Shams University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This is a prospective intervention study to assess the effectiveness of both the live attenuated and messenger RNA vaccines against SARS-CoV-2 infection
Detailed Description
This is a prospective intervention study to assess the short-term effectiveness of the first dose of both the live attenuated and messenger RNA vaccines against SARS-CoV-2 infection by monitoring the ...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Candidate for receiving vaccination according to health care authorties prioritaizaton
Exclusion
- SARS-CoV-2 recovered cases \<3 months
- Individuals who are currently infected with Sars-COV-2 and/or with respiratory symptoms with fever.
Key Trial Info
Start Date :
February 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04885764
Start Date
February 23 2021
End Date
December 1 2021
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, Egypt, 11566